Saroja Pharma Industries India Limited

NSE: SAROJA · Unclassified

₹38.80+0.00%04 Nov 2026

Ask the data

Instant answers about Saroja Pharma Industries India Limited — computed from its filings, no language model

Market cap₹16 cr

Current price₹38.80

High / Low₹65 / ₹28

P/E9.6

P/B0.90

Book value₹43.2

ROE9.3%

ROCE11.7%

Debt / equity0.83

Dividend yield—

EPS (TTM)₹4.03

Face value₹10

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

	FY24	FY25	FY26
Revenue	40.7	53.7	70.1
EBITDA	2.5	2.8	3.7
Operating margin	6.3%	5.2%	5.3%
Interest	1.4	1.4	1.5
Depreciation	0.1	0.1	0.1
Profit before tax	1.2	1.4	2.2
Tax	0.3	0.4	0.6
Net profit	0.9	1.0	1.6
EPS ₹	0.00	0.00	4.02
Operating cash flow	2.2	22.4	7.4
Capex	0.0	0.1	11.9
Dividend paid	0.0	0.0	0.0
Total assets	—	39.5	41.8
Equity	—	15.7	17.3

Half-yearly performance

last 6 half years · ₹ crore

	H1 FY24	H2 FY24	H1 FY25	H2 FY25	H1 FY26	H2 FY26
Revenue	21.1	19.6	18.7	35.0	38.4	31.8
Operating profit	1.2	1.4	1.1	1.6	1.0	2.7
Operating margin	5.5%	7.1%	6.0%	4.7%	2.5%	8.6%
Other income	0.4	-0.2	0.1	0.1	0.4	-0.3
Interest	0.8	0.6	0.7	0.7	0.5	0.9
Depreciation	0.0	0.1	0.1	0.1	0.1	0.1
Profit before tax	0.7	0.5	0.5	1.0	0.8	1.5
Tax	0.2	0.1	0.1	0.3	0.2	0.4
Net profit	0.5	0.4	0.3	0.7	0.6	1.0
EPS ₹	1.68	0.00	0.00	0.00	1.42	2.60
Revenue YoY	—	—	-11.4%	79.0%	104.9%	-9.2%
Profit YoY	—	—	-32.0%	84.2%	67.6%	48.6%

Returns & margins

trailing-twelve-month, per half year

	H2 FY24	H1 FY25	H2 FY25	H1 FY26	H2 FY26
ROE	6.0%	4.8%	6.6%	7.8%	9.3%
ROCE	9.8%	9.6%	11.3%	11.3%	11.7%
Net margin	2.2%	1.9%	1.9%	1.7%	2.3%
EBITDA margin	6.3%	6.6%	5.2%	3.6%	5.3%
Debt / equity	0.84	0.58	0.60	0.65	0.83
Interest coverage	1.83	1.74	2.02	2.41	2.53
Asset turnover	1.21	1.32	1.36	1.99	1.68

Balance sheet

equity vs borrowings over time · ₹ crore

	SEP '23	SEP '24	MAR '25	SEP '25	MAR '26
Share capital	4.0	4.0	4.0	4.0	4.0
Other equity / reserves	8.0	11.0	11.7	12.2	13.3
Total equity	14.7	15.0	15.7	16.2	17.3
Borrowings	12.3	8.8	9.5	10.5	14.4
Current liabilities	13.7	11.9	22.5	17.6	17.1
Non-current liabilities	5.4	2.0	1.4	3.1	7.4
Total assets	33.8	28.9	39.5	36.9	41.8
Property, plant & equipment	2.8	2.5	2.5	2.6	2.2
Investments	0.4	0.2	0.3	0.4	0.5
Inventories	0.0	0.3	0.1	1.1	0.9
Receivables	19.1	17.6	26.6	18.5	17.3
Cash & equivalents	7.6	1.3	0.3	2.1	0.3

Cash flow

annual · ₹ crore · line = free cash flow

	FY24	FY25	FY26
Cash from operations	2.2	22.4	7.4
Cash from investing	-4.7	-2.7	-11.7
Cash from financing	6.6	1.6	4.2
Capex	0.0	0.1	11.9
Free cash flow	2.2	22.2	-4.5
Dividends paid	0.0	0.0	0.0

Where the assets sit

Mar '26 · ₹ crore

Fixed assets (PPE)

₹2.2 cr5%

Investments

₹0.5 cr1%

Inventories

₹0.9 cr2%

Receivables

₹17.3 cr41%

Cash & equivalents

₹0.3 cr1%

Other assets

₹20.5 cr49%

Peer comparison

largest in Unclassified · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Avantel Limited	36,86,04,549	138.69	—	1059360.68	0.0%
Ducol Organics And Colours Limited	19,55,275	120.00	—	20089.13	0.0%
Jio Platforms Limited	12,57,181	1,406.40	—	3.57	—
SBI Funds Management Limited	1,01,750	499.55	—	—	—
Tamilnadu Telecommunication Limited	91,314	9.93	—	—	—
Manipal Health Enterprises Limited	76,294	646.70	—	—	—
INDO-MIM Limited	59,042	1,219.50	—	—	—
AvenuesAI Limited	45,138	129.25	153.6	9.51	6.2%
Dhoot Transmission Limited	32,761	1,601.60	—	8.11	—
3M India Limited	31,071	27,570.00	53.8	17.57	32.7%
Saroja Pharma Industries India Limited	16	38.80	9.6	0.90	9.3%

StoxGud checklist: Neutral setup · 4/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month+23.4%

6 months-1.1%

1 year-38.1%

3Y CAGR-14.5%

5Y CAGR—

10Y CAGR—

50-day avg₹34.75

200-day avg₹40.10

RSI (14)42

FAQs

What is the share price of Saroja Pharma Industries India Limited?

Saroja Pharma Industries India Limited (SAROJA) closed at ₹38.80 on NSE on 04 Nov 2026.

What is the market cap of Saroja Pharma Industries India Limited?

₹16 crore at the latest close.

What is the P/E ratio of Saroja Pharma Industries India Limited?

9.6, on trailing-twelve-month earnings from its filings.

How fast is Saroja Pharma Industries India Limited growing?

Saroja Pharma Industries India Limited: Latest-half-year revenue is down 9.2% year on year, profit up 48.6%.

How profitable is Saroja Pharma Industries India Limited?

On a trailing-twelve-month basis return on equity is 9.3%, return on capital employed 11.7%, operating margin 5.3%, net margin 2.3%.

How much debt does Saroja Pharma Industries India Limited have?

Saroja Pharma Industries India Limited is moderately geared: debt to equity is 0.83 with borrowings of ₹14 cr against cash of ₹0 cr (balance sheet of 2026-03-31). Operating profit covers interest 2.5 times.

Financials parsed from Saroja Pharma Industries India Limited's own XBRL filings to NSE (standalone), ₹ crore unless marked. Half-yearly from H1 FY24, annual from FY24, balance sheet from Sep '23. * = derived (full year minus the other half). This company is on NSE's SME platform and reports results half-yearly. Information only, not investment advice.